Delivering microparticles loaded with antimicrobial agents, direct to infective site, avoids problems of antibiotic resistance
Regenerative medicine platform technology has potential in areas beyond wound care
FDA green light for commercialisation of diabetic foot ulcer graft
Bolting on TEI will enhance Integra’s position and allow it to expand into attractive adjacent markets
Two technologies that promise a lot in burns treatment and wound care respectively need more evidence before UK’s NICE will support their adoption.
Has the truth serum that is a double blinded, placebo controlled study uncovered the real effect (or lack of) of a previously hopeful new treatment?
Smith & Nephew is to offer a no-frills service to joint customers in the U.S., but what this amounts to other than not having the rep in attendance, is unclear.
Cynosure, Inc., has received FDA 510(k) clearance for its flagship PicoSure Picosecond Laser Workstation for the treatment of acne scars.
Kinetic Concepts, Inc. has announced the EU launch of its CelluTome™ Epidermal Harvesting System, delivering an automated, precise and reproducible process of harvesting autologous epidermal tissue for grafting.
A newly FDA approved syringe-based dispenser of absorbent sponges aims to stop the flow of blood from gunshot wounds.
The U.S. FDA has granted 510(k) clearance for Devon Medical Products to market its extriCARE® 3600 Negative Pressure Wound Therapy (NPWT) pump and foam dressing kit.
ZipLine Medical says its Zip® Non-invasive surgical skin closure device is faster than sutures, can produce superior cosmesis compared to staples and reduce the risk of surgical site infection.
The UK’s National Institute for Health and Care Excellence (NICE) has opened its consultation on draft guidance for a ‘spray-on skin’ device that aims to help improve the healing of acute burns.
Healthcare products company Medline is showcasing many products at AORN this weekend, but is using the event to launch Surgiseal Twist, a new delivery device for a cyanoacrylate topical skin adhesive.
The UK’s National Institute for Health and Clinical Excellence (NICE) has published new medical technology guidance supporting a device that aims to help improve the treatment of wounds.
A newly published, prospective, randomised, comparative study suggests that diabetic foot ulcers are mostly healed with the application of MiMedx’s EpiFix allograft. And it seems weekly application speeds things up compared with bi-weekly.